Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.10.0.1
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2016 $ 1 $ 40,895 $ 33,349,144 $ (26,082,960) $ 7,307,080
Balance, shares at Dec. 31, 2016 1,000 40,895,037        
Net loss
Balance at Dec. 31, 2017 $ 1 $ 40,895 33,349,144 (26,082,960) 7,307,080
Balance, shares at Dec. 31, 2017 1,000 40,895,037        
Issuance of shares and warrants for cash $ 155 465,345   465,500
Issuance of shares and warrants for cash, shares 155,167        
Issuance of shares for cash $ 928 3,058,836   3,059,764
Issuance of shares for cash, shares 928,504        
Issuance of shares for services $ 1,953 9,901,059   9,903,012
Issuance of shares for services, shares 1,953,134        
Shares purchased, not issued as of statement date $ 1,020 1,273,480   1,274,500
Shares purchased, not issued as of statement date, shares 1,019,600        
Shares authorized for services, not issued as of statement date   $ 44 70,291   70,335
Shares authorized for services, not issued as of statement date, shares   43,602        
Shares issued for purchase of patents $ 200 949,800   950,000
Shares issued for purchase of patents, shares 200,000        
Purchase of Spirulinex, LLC joint venture interest (662,721) 662,721
Capital contributed by minority joint ventures 1,390 1,390
Net loss (13,647,636) (409,701) (14,057,337)
Balance at Sep. 30, 2018 $ 1 $ 45,195 $ 48,405,234 $ (39,730,596) $ 254,410 $ 8,974,244
Balance, shares at Sep. 30, 2018 1,000 45,195,044